Chuanrui Xu

Huazhong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Spatial multi-omics identifies a NOTCH3-mediated capillary-mCAF crosstalk driving immune exclusion in hepatocellular carcinoma.

Journal: iMeta

Published: January 29, 2026

YBX1-LDHB axis orchestrates pyruvate production from lactate to promote ICC initiation and development.

YBX1-LDHB axis orchestrates pyruvate production from lactate to promote ICC initiation and development.

Journal: Pharmacological research

Published: October 02, 2025

Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms.

Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms.

Journal: Cancer letters

Published: March 18, 2025

Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice.

Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice.

Journal: Frontiers in pharmacology

Published: February 10, 2025

Evaluation of anti-tumor activity of borated camptothecin derivatives targeting topoisomerase 1 against hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Evaluation of anti-tumor activity of borated camptothecin derivatives targeting topoisomerase 1 against hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Journal: Bioorganic chemistry

Published: February 06, 2025

Improving dynamic control of toehold-mediated strand displacement reactions through phosphorothioate modifications.

Improving dynamic control of toehold-mediated strand displacement reactions through phosphorothioate modifications.

Journal: Nanoscale

Published: November 18, 2024

Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.

Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.

Journal: Oncogene

Published: November 23, 2023

microRNA-203 functions as a natural Ras inhibitor in hepatocellular carcinoma.

microRNA-203 functions as a natural Ras inhibitor in hepatocellular carcinoma.

Journal: American journal of cancer research

Published: September 28, 2022

Glioma Shapes Blood-Brain Barrier Integrity and Remodels the Tumor Microenvironment: Links with Clinical Features and Prognosis.

Glioma Shapes Blood-Brain Barrier Integrity and Remodels the Tumor Microenvironment: Links with Clinical Features and Prognosis.

Journal: Journal of clinical medicine

Published: July 21, 2022

Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma.

Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma.

Journal: Frontiers in genetics

Published: June 29, 2022

Coronavirus subverts ER-phagy by hijacking FAM134B and ATL3 into p62 condensates to facilitate viral replication.

Coronavirus subverts ER-phagy by hijacking FAM134B and ATL3 into p62 condensates to facilitate viral replication.

Journal: Cell reports

Published: April 27, 2022

β-Catenin signaling in hepatocellular carcinoma.

β-Catenin signaling in hepatocellular carcinoma.

Journal: The Journal of clinical investigation

Published: February 15, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026